retatrutide triple agonist obesity trial ⭐️topline results from TRIUMPH-1, a Phase 3 clinical evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon hormone receptor agonist, in adults with or “overweight” Retatrutide Obesity Triple Agonist Targeting

These findings are reassuring, but they do not provide a definitive answer for all situations

All authors participated in interpretation of the data and critical review of the paper, had full access to the data, and had responsibility for the decision to submit for publication

Aim for at least 150 minutes of moderate to vigorous exercise each week

It is to make smaller meals more complete, so each one still supports muscle, digestion, hydration, and nutrient status

All research must comply with applicable institutional, national, and international regulations

Half the plate non-starchy vegetables providing fiber and micronutrients